COSIMPLI Trademark

Trademark Overview

On Friday, September 6, 2019, a trademark application was filed for COSIMPLI with the United States Patent and Trademark Office. The USPTO has given the COSIMPLI trademark a serial number of 88607078. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by Pfizer Inc.. The COSIMPLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
cosimpli

General Information

Serial Number88607078
Word MarkCOSIMPLI
Filing DateFriday, September 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 17, 2022SOU EXTENSION 5 GRANTED
Friday, August 5, 2022SOU EXTENSION 5 FILED
Tuesday, August 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 5, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 4 GRANTED
Friday, February 4, 2022SOU EXTENSION 4 FILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 3, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 3, 2021SOU EXTENSION 3 FILED
Tuesday, August 3, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 2, 2021SOU EXTENSION 2 GRANTED
Tuesday, February 2, 2021SOU EXTENSION 2 FILED
Tuesday, February 2, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 1 GRANTED
Monday, August 10, 2020SOU EXTENSION 1 FILED
Monday, August 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 2, 2019ASSIGNED TO LIE
Monday, November 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 19, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, November 19, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 19, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, November 19, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Tuesday, September 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2019NEW APPLICATION ENTERED

Related Keywords

cosimpli preparations pharmaceutical disorders dysfunction treatment erectile sexual liver diseases viral